Panbela to participate in the roth inaugural healthcare opportunities conference

Minneapolis, oct. 06, 2022 (globe newswire) -- panbela therapeutics, inc. (nasdaq: pbla ), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, announced today that management will participate in the inaugural roth healthcare opportunities conference on october 6, 2022, in new york, ny. this invitation only event provides a forum for public healthcare companies to tell their stories to investors. the conference will consist of a 10-minute company presentation to the attendee audience, as well as one-on-one investor meetings.
PBLA Ratings Summary
PBLA Quant Ranking